Dasatinib-induced colitis: discovering the side effects of immunotherapy

Rev Esp Enferm Dig. 2020 Aug;112(8):663-664. doi: 10.17235/reed.2020.6789/2019.


The effects of immunotherapy are numerous and are still being discovered. We present a case report of a patient who received dasatinib for chronic myeloid leukemia. A colonoscopy was performed due to a positive fecal occult blood test and colitis was observed. Furthermore, she also had a cytomegalovirus infection. This case highlights the importance to detect cases of immunomodulatory drugs induced colitis by the fecal occult blood test.

Publication types

  • Case Reports

MeSH terms

  • Colitis* / chemically induced
  • Dasatinib / adverse effects
  • Female
  • Humans
  • Immunotherapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Occult Blood


  • Dasatinib